A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma — Stella

Home/Primary Open Angle Glaucoma (POAG)/

View on ClinicalTrials.gov

Recruiting

Back to Primary Open Angle Glaucoma (POAG) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Denmark

Department of Ophthalmology, Rigshospitalet, Glostrup Municipality

Key details

Phase

Post-approval study

Sponsor

Glostrup University Hospital, Copenhagen

Enrollment target

~126 participants

Started

January 2025

Primary completion

August 2028

Age range

45 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.